Next 20 Records New Search

Your search found 43 records, sorted by year and then date of acquisition.

1. Protocol Information: CTN-0036-Ot - Epidemiology and Ethnographic Survey of "Cheese" Heroin Use among Hispanics in Dallas County doc type
  CTN Dissemination Library protocol page
 
2. Comparative Effectiveness of Extended-Release Naltrexone Versus Buprenorphine-Naloxone for Opioid Relapse Prevention (X:BOT): A Multicentre, Open-Label, Randomised Controlled Trial. doc type doc type
  Lee, Joshua D. ; Nunes, Edward V. ; Novo, Patricia ; Bachrach, Ken ; Bailey, Genie L. ; Bhatt, Snehal ; Farkas, Sarah ; Fishman, Marc J. ; Gauthier, Phoebe ; Hodgkins, Candace C. ; King, Jacquie ; Lindblad, Robert ; Liu, David S. ; Matthews, Abigail G. ; May, Jeanine ; Peavy, K. Michelle ; Ross, Stephen ; Salazar, Dagmar ; Schkolnik, Paul ; Shmueli-Blumberg, Dikla ; Stablein, Don ; Subramaniam, Geetha A. ; Rotrosen, John
 The Lancet 2017 (in press). [doi: 10.1016/S0140-6736(17)32812-X].
 
3. DSM-5 Substance Use Disorders Among Adult Primary Care Patients: Results from a Multisite Study. doc type
  Wu, Li-Tzy ; McNeely, Jennifer ; Subramaniam, Geetha A. ; Brady, Kathleen T. ; Sharma, Gaurav ; VanVeldhuisen, Paul C. ; Zhu, He ; Schwartz, Robert P.
 Drug and Alcohol Dependence 2017;179:42-46. [doi: 10.1016/j.drugalcdep.2017.05.048].
 
4. High Mortality Among Patients with Opioid Use Disorder in a Large Healthcare System. doc type
  Hser, Yih-Ing ; Mooney, Larissa J. ; Saxon, Andrew J. ; Miotto, Karen ; Bell, Douglas S. ; Zhu, Yuhui ; Liang, Di ; Huang, David
 Journal of Addiction Medicine 2017;11(4):315-319. [doi: 10.1097/ADM.0000000000000312].
 
5. The Prescription Opioid Addiction Treatment Study: What Have We Learned. doc type
  Weiss, Roger D. ; Rao, Vinod
 Drug and Alcohol Dependence 2017;173:S48-S54. [doi: 10.1016/j.drugalcdep.2016.12.001].
 
6. Distinctive Trajectories of Opioid Use Over an Extended Follow-Up of Patients in a Multisite Trial on Buprenorphine + Naloxone and Methadone. doc type
  Hser, Yih-Ing ; Huang, David ; Saxon, Andrew J. ; Woody, George ; Moskowitz, Andrew L. ; Matthews, Abigail G. ; Ling, Walter
 Journal of Addiction Medicine 2017;11(1):63-69. [doi: 10.1097/ADM.0000000000000274].
 
7. Causes of Death and Expected Years of Life Lost Among Treated Opioid-Dependent Individuals in the United States and Taiwan. doc type
  Chang, Kun-Chia ; Wang, Jung-Der ; Saxon, Andrew J. ; Matthews, Abigail G. ; Woody, George E. ; Hser, Yih-Ing
 International Journal of Drug Policy 2017;45:1-6. [doi: 10.1016/j.drugpo.2016.12.003].
 
8. Ethical and Clinical Safety Considerations in the Design of an Effectiveness Trial: A Comparison of Buprenorphine Versus Naltrexone Treatment for Opioid Dependence. doc type
  Nunes, Edward V. ; Lee, Joshua D. ; Sisti, Dominic ; Segal, Andrea ; Caplan, Arthur ; Fishman, Marc J. ; Bailey, Genie L. ; Brigham, Gregory S. ; Novo, Patricia ; Farkas, Sarah ; Rotrosen, John
 Contemporary Clinical Trials 2016;51:34-43. [doi: 10.1016/j.cct.2016.09.006].
 
9. NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study Design and Rationale. doc type
  Lee, Joshua D. ; Nunes, Edward V. ; Novo, Patricia ; Bailey, Genie L. ; Brigham, Gregory S. ; Cohen, Allan J. ; Fishman, Marc J. ; Ling, Walter ; Lindblad, Robert ; Shmueli-Blumberg, Dikla ; Stablein, Don ; May, Jeanine ; Salazar, Dagmar ; Liu, David S. ; Rotrosen, John
 Contemporary Clinical Trials 2016;50:253-264. [doi: 10.1016/j.cct.2016.08.004].
 
10. Hair Analysis and Its Concordance with Self-Report for Drug Users Presenting in Emergency Departments. doc type
  Sharma, Gaurav ; Oden, Neal L. ; VanVeldhuisen, Paul C. ; Bogenschutz, Michael P.
 Drug and Alcohol Dependence 2016;167:149-155. [doi: 10.1016/j.drugalcdep.2016.08.007].
 
11. Changes in Quality of Life in Cocaine-Dependent Participants Provided Treatment with Buprenorphine+Naloxone Combined with Extended Release Naltrexone. doc type
  Shmueli-Blumberg, Dikla ; Carrizales, Fermin A. ; Kazanis, William H. ; Hillhouse, Maureen ; Matthews, Abigail ; Potter, Jennifer Sharpe
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Palm Springs, CA, June 11-16, 2016.
 
12. Participant Treatment Assignment Perceptions in the NIDA CTN Cocaine Use Reduction with Buprenorphine (CURB) Study. doc type
  Matthews, Abigail G. ; Hillhouse, Maureen ; Thomas, Christie ; Ling, Walter ; Shmueli-Blumberg, Dikla
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Palm Springs, CA, June 11-16, 2016.
 
13. Long-Term Outcomes After Randomization to Buprenorphine/Naloxone Versus Methadone in a Multi-Site Trial. doc type
  Hser, Yih-Ing ; Evans, Elizabeth ; Huang, David ; Weiss, Roger D. ; Saxon, Andrew J. ; Carroll, Kathleen M. ; Woody, George E. ; Liu, David S. ; Wakim, Paul G. ; Matthews, Abigail G. ; Hatch-Maillette, Mary A. ; Jelstrom, Eve ; Wiest, Katharina L. ; McLaughlin, Paul ; Ling, Walter
 Addiction 2016;111(4):695-705. [doi: 10.1111/add.13238].
 
14. Predictors of Agreement Between Hair Analysis and Self Report of Drug Use. doc type
  VanVeldhuisen, Paul C. ; Sharma, Gaurav ; Bogenschutz, Michael P.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Phoenix, AZ, June 13-18, 2015.
 
15. Opioid Addicted Buprenorphine Injectors: Drug Use During and After 12-Weeks of Buprenorphine-Naloxone or Methadone in the Republic of Georgia. doc type
  Piralishvili, Gvantsa ; Otiashvili, David ; Sikharulidze, Zura ; Kamkamidze, George ; Poole, Sabrina A. ; Woody, George E.
 Journal of Substance Abuse Treatment 2015;50:32-37. [doi: 10.1016/j.jsat.2014.10.003].
 
16. Long-term Outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Griffin, Margaret L. ; Provost, Scott E. ; Fitzmaurice, Garrett M. ; McDermott, Katherine A. ; Srisarajivakul, Emily N. ; Dodd, Dorian R. ; Dreifuss, Jessica A. ; McHugh, R. Kathryn ; Carroll, Kathleen M.
 Drug and Alcohol Dependence 2015;150:112-119. [doi: 10.1016/j.drugalcdep.2015.02.030].
 
17. Web-Based Treatment for Substance Use Disorders: Differential Effects by Primary Substance. doc type
  Cochran, Gerald ; Stitzer, Maxine L. ; Campbell, Aimee N. C. ; Hu, Mei-Chen ; Vandrey, Ryan ; Nunes, Edward V.
 Addictive Behaviors 2015;45:191-194. [doi: 10.1016/j.addbeh.2015.02.002].
 
18. The Multi-Site Prescription Opioid Addiction Treatment Study: 18-Month Outcomes. doc type
  Potter, Jennifer Sharpe ; Dreifuss, Jessica A. ; Marino, Elise N. ; Provost, Scott E. ; Dodd, Dorian R. ; Rice, Lindsay S. ; Fitzmaurice, Garrett M. ; Griffin, Margaret L. ; Weiss, Roger D.
 Journal of Substance Abuse Treatment 2015;48(1):62-69. [doi: 10.1016/j.jsat.2014.07.009].
 
19. Association Between Hepatitis C Virus and Opioid Use While in Buprenorphine Treatment: Preliminary Findings. doc type
  Murphy, Sean M. ; Dweik, Dana ; McPherson, Sterling ; Roll, John M.
 American Journal of Drug and Alcohol Abuse 2014;41(1):88-92. [doi: 10.3109/00952990.2014.983274].
 
20. Characteristics of Mexican and Mexican American Adolescents in Treatment for "Cheese" Heroin Use. doc type
  Walker, N. Robrina ; Maxwell, Jane C. ; Adinoff, Bryon H. ; Carmody, Thomas ; Coton, Casey E. ; Tirado, Carlos F.
 Journal of Ethnicity in Substance Abuse 2014;13:258-272. [doi: 10.1080/15332640.2014.883582].
 

  Next 20 Records New Search